APO Research
Talk to an analyst

APO RESEARCH · REPORT

Haemophilus Influenzae Type B Injection Vaccine

Compare research editions
View pricing & licenses

Selected research

Industry Research

Haemophilus Influenzae Type B Injection Vaccine Industry Research Report 2026

29 December 2025126 pages

Choose your research edition.

Industry ResearchHaemophilus Influenzae Type B Injection Vaccine Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Haemophilus Influenzae Type B Injection Vaccine Industry Growth and Trends Forecast to 2032108 pages · $3,450 USDMarket StructureGlobal Haemophilus Influenzae Type B Injection Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Haemophilus Influenzae Type B Injection Vaccine Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Haemophilus Influenzae Type B Injection Vaccine Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Haemophilus Influenzae Type B Injection Vaccine market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Haemophilus Influenzae Type B Injection Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Haemophilus Influenzae Type B Injection Vaccine is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Haemophilus Influenzae Type B Injection Vaccine is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Haemophilus Influenzae Type B Injection Vaccine include Bharat Biotech, Biokangtai, Glaxosmithkline, Olymvax, Sanofi Pasteur, Walvax Biotechnology, Beijing Minhai Biotechnology Co., Ltd, Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd and Chengdu Oulin Biotechnology Co., Ltd, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Haemophilus Influenzae Type B Injection Vaccine market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Haemophilus Influenzae Type B Injection Vaccine Market by Company

Bharat Biotech

Biokangtai

Glaxosmithkline

Olymvax

Sanofi Pasteur

Walvax Biotechnology

Beijing Minhai Biotechnology Co., Ltd

Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd

Chengdu Oulin Biotechnology Co., Ltd

Chengdu Institute of Biological Products Co., Ltd

Lanzhou Institute of Biological Products Co., Ltd

Yuxi Watson Biotechnology Co., Ltd

Haemophilus Influenzae Type B Injection Vaccine Segment by Type

Lyophilized

Non-lyophilized

Haemophilus Influenzae Type B Injection Vaccine Segment by Application

Hospital

Clinic

Haemophilus Influenzae Type B Injection Vaccine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Haemophilus Influenzae Type B Injection Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Haemophilus Influenzae Type B Injection Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Haemophilus Influenzae Type B Injection Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Haemophilus Influenzae Type B Injection Vaccine manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Haemophilus Influenzae Type B Injection Vaccine by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Haemophilus Influenzae Type B Injection Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Haemophilus Influenzae Type B Injection Vaccine Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Haemophilus Influenzae Type B Injection Vaccine Sales (K Units) of Manufacturers (2021-2026) Table 7. Global Haemophilus Influenzae Type B Injection Vaccine Sales Market Share by Manufacturers (2021-2026) Table 8. Global Haemophilus Influenzae Type B Injection Vaccine Revenue of Manufacturers (2021-2026) Table 9. Global Haemophilus Influenzae Type B Injection Vaccine Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Haemophilus Influenzae Type B Injection Vaccine Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global Haemophilus Influenzae Type B Injection Vaccine Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Haemophilus Influenzae Type B Injection Vaccine, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Haemophilus Influenzae Type B Injection Vaccine, Product Type & Application Table 14. Global Haemophilus Influenzae Type B Injection Vaccine Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Haemophilus Influenzae Type B Injection Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Bharat Biotech Company Information Table 19. Bharat Biotech Business Overview Table 20. Bharat Biotech Haemophilus Influenzae Type B Injection Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. Bharat Biotech Haemophilus Influenzae Type B Injection Vaccine Product Portfolio Table 22. Bharat Biotech Recent Developments Table 23. Biokangtai Company Information Table 24. Biokangtai Business Overview Table 25. Biokangtai Haemophilus Influenzae Type B Injection Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. Biokangtai Haemophilus Influenzae Type B Injection Vaccine Product Portfolio Table 27. Biokangtai Recent Developments Table 28. Glaxosmithkline Company Information Table 29. Glaxosmithkline Business Overview Table 30. Glaxosmithkline Haemophilus Influenzae Type B Injection Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. Glaxosmithkline Haemophilus Influenzae Type B Injection Vaccine Product Portfolio Table 32. Glaxosmithkline Recent Developments Table 33. Olymvax Company Information Table 34. Olymvax Business Overview Table 35. Olymvax Haemophilus Influenzae Type B Injection Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. Olymvax Haemophilus Influenzae Type B Injection Vaccine Product Portfolio Table 37. Olymvax Recent Developments Table 38. Sanofi Pasteur Company Information Table 39. Sanofi Pasteur Business Overview Table 40. Sanofi Pasteur Haemophilus Influenzae Type B Injection Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 41. Sanofi Pasteur Haemophilus Influenzae Type B Injection Vaccine Product Portfolio Table 42. Sanofi Pasteur Recent Developments Table 43. Walvax Biotechnology Company Information Table 44. Walvax Biotechnology Business Overview Table 45. Walvax Biotechnology Haemophilus Influenzae Type B Injection Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Walvax Biotechnology Haemophilus Influenzae Type B Injection Vaccine Product Portfolio Table 47. Walvax Biotechnology Recent Developments Table 48. Beijing Minhai Biotechnology Co., Ltd Company Information Table 49. Beijing Minhai Biotechnology Co., Ltd Business Overview Table 50. Beijing Minhai Biotechnology Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. Beijing Minhai Biotechnology Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Product Portfolio Table 52. Beijing Minhai Biotechnology Co., Ltd Recent Developments Table 53. Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Company Information Table 54. Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Business Overview Table 55. Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 56. Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Product Portfolio Table 57. Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Recent Developments Table 58. Chengdu Oulin Biotechnology Co., Ltd Company Information Table 59. Chengdu Oulin Biotechnology Co., Ltd Business Overview Table 60. Chengdu Oulin Biotechnology Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Chengdu Oulin Biotechnology Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Product Portfolio Table 62. Chengdu Oulin Biotechnology Co., Ltd Recent Developments Table 63. Chengdu Institute of Biological Products Co., Ltd Company Information Table 64. Chengdu Institute of Biological Products Co., Ltd Business Overview Table 65. Chengdu Institute of Biological Products Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Chengdu Institute of Biological Products Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Product Portfolio Table 67. Chengdu Institute of Biological Products Co., Ltd Recent Developments Table 68. Lanzhou Institute of Biological Products Co., Ltd Company Information Table 69. Lanzhou Institute of Biological Products Co., Ltd Business Overview Table 70. Lanzhou Institute of Biological Products Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Lanzhou Institute of Biological Products Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Product Portfolio Table 72. Lanzhou Institute of Biological Products Co., Ltd Recent Developments Table 73. Yuxi Watson Biotechnology Co., Ltd Company Information Table 74. Yuxi Watson Biotechnology Co., Ltd Business Overview Table 75. Yuxi Watson Biotechnology Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Yuxi Watson Biotechnology Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Product Portfolio Table 77. Yuxi Watson Biotechnology Co., Ltd Recent Developments Table 78. Global Haemophilus Influenzae Type B Injection Vaccine Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 79. Global Haemophilus Influenzae Type B Injection Vaccine Sales by Region (2021-2026) & (K Units) Table 80. Global Haemophilus Influenzae Type B Injection Vaccine Sales Market Share by Region (2021-2026) Table 81. Global Haemophilus Influenzae Type B Injection Vaccine Sales by Region (2027-2032) & (K Units) Table 82. Global Haemophilus Influenzae Type B Injection Vaccine Sales Market Share by Region (2027-2032) Table 83. Global Haemophilus Influenzae Type B Injection Vaccine Revenue by Region (2021-2026) & (US$ Million) Table 84. Global Haemophilus Influenzae Type B Injection Vaccine Revenue Market Share by Region (2021-2026) Table 85. Global Haemophilus Influenzae Type B Injection Vaccine Revenue by Region (2027-2032) & (US$ Million) Table 86. Global Haemophilus Influenzae Type B Injection Vaccine Revenue Market Share by Region (2027-2032) Table 87. North America Haemophilus Influenzae Type B Injection Vaccine Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 88. North America Haemophilus Influenzae Type B Injection Vaccine Sales by Country (2021-2026) & (K Units) Table 89. North America Haemophilus Influenzae Type B Injection Vaccine Sales by Country (2027-2032) & (K Units) Table 90. North America Haemophilus Influenzae Type B Injection Vaccine Revenue by Country (2021-2026) & (US$ Million) Table 91. North America Haemophilus Influenzae Type B Injection Vaccine Revenue by Country (2027-2032) & (US$ Million) Table 92. Europe Haemophilus Influenzae Type B Injection Vaccine Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 93. Europe Haemophilus Influenzae Type B Injection Vaccine Sales by Country (2021-2026) & (K Units) Table 94. Europe Haemophilus Influenzae Type B Injection Vaccine Sales by Country (2027-2032) & (K Units) Table 95. Europe Haemophilus Influenzae Type B Injection Vaccine Revenue by Country (2021-2026) & (US$ Million) Table 96. Europe Haemophilus Influenzae Type B Injection Vaccine Revenue by Country (2027-2032) & (US$ Million) Table 97. Asia Pacific Haemophilus Influenzae Type B Injection Vaccine Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 98. Asia Pacific Haemophilus Influenzae Type B Injection Vaccine Sales by Country (2021-2026) & (K Units) Table 99. Asia Pacific Haemophilus Influenzae Type B Injection Vaccine Sales by Country (2027-2032) & (K Units) Table 100. Asia Pacific Haemophilus Influenzae Type B Injection Vaccine Revenue by Country (2021-2026) & (US$ Million) Table 101. Asia Pacific Haemophilus Influenzae Type B Injection Vaccine Revenue by Country (2027-2032) & (US$ Million) Table 102. South America Haemophilus Influenzae Type B Injection Vaccine Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 103. South America Haemophilus Influenzae Type B Injection Vaccine Sales by Country (2021-2026) & (K Units) Table 104. South America Haemophilus Influenzae Type B Injection Vaccine Sales by Country (2027-2032) & (K Units) Table 105. South America Haemophilus Influenzae Type B Injection Vaccine Revenue by Country (2021-2026) & (US$ Million) Table 106. South America Haemophilus Influenzae Type B Injection Vaccine Revenue by Country (2027-2032) & (US$ Million) Table 107. Middle East and Africa Haemophilus Influenzae Type B Injection Vaccine Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 108. Middle East and Africa Haemophilus Influenzae Type B Injection Vaccine Sales by Country (2021-2026) & (K Units) Table 109. Middle East and Africa Haemophilus Influenzae Type B Injection Vaccine Sales by Country (2027-2032) & (K Units) Table 110. Middle East and Africa Haemophilus Influenzae Type B Injection Vaccine Revenue by Country (2021-2026) & (US$ Million) Table 111. Middle East and Africa Haemophilus Influenzae Type B Injection Vaccine Revenue by Country (2027-2032) & (US$ Million) Table 112. Global Haemophilus Influenzae Type B Injection Vaccine Sales by Type (2021-2026) & (K Units) Table 113. Global Haemophilus Influenzae Type B Injection Vaccine Sales by Type (2027-2032) & (K Units) Table 114. Global Haemophilus Influenzae Type B Injection Vaccine Sales Market Share by Type (2021-2026) Table 115. Global Haemophilus Influenzae Type B Injection Vaccine Sales Market Share by Type (2027-2032) Table 116. Global Haemophilus Influenzae Type B Injection Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 117. Global Haemophilus Influenzae Type B Injection Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 118. Global Haemophilus Influenzae Type B Injection Vaccine Revenue Market Share by Type (2021-2026) Table 119. Global Haemophilus Influenzae Type B Injection Vaccine Revenue Market Share by Type (2027-2032) Table 120. Global Haemophilus Influenzae Type B Injection Vaccine Price by Type (2021-2026) & (US$/Unit) Table 121. Global Haemophilus Influenzae Type B Injection Vaccine Price by Type (2027-2032) & (US$/Unit) Table 122. Global Haemophilus Influenzae Type B Injection Vaccine Sales by Application (2021-2026) & (K Units) Table 123. Global Haemophilus Influenzae Type B Injection Vaccine Sales by Application (2027-2032) & (K Units) Table 124. Global Haemophilus Influenzae Type B Injection Vaccine Sales Market Share by Application (2021-2026) Table 125. Global Haemophilus Influenzae Type B Injection Vaccine Sales Market Share by Application (2027-2032) Table 126. Global Haemophilus Influenzae Type B Injection Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 127. Global Haemophilus Influenzae Type B Injection Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 128. Global Haemophilus Influenzae Type B Injection Vaccine Revenue Market Share by Application (2021-2026) Table 129. Global Haemophilus Influenzae Type B Injection Vaccine Revenue Market Share by Application (2027-2032) Table 130. Global Haemophilus Influenzae Type B Injection Vaccine Price by Application (2021-2026) & (US$/Unit) Table 131. Global Haemophilus Influenzae Type B Injection Vaccine Price by Application (2027-2032) & (US$/Unit) Table 132. Key Raw Materials Table 133. Raw Materials Key Suppliers Table 134. Haemophilus Influenzae Type B Injection Vaccine Distributors List Table 135. Haemophilus Influenzae Type B Injection Vaccine Customers List Table 136. Haemophilus Influenzae Type B Injection Vaccine Industry Trends Table 137. Haemophilus Influenzae Type B Injection Vaccine Industry Drivers Table 138. Haemophilus Influenzae Type B Injection Vaccine Industry Restraints Table 139. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Haemophilus Influenzae Type B Injection Vaccine Product Image Figure 5. Global Haemophilus Influenzae Type B Injection Vaccine Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Haemophilus Influenzae Type B Injection Vaccine Market Size (2021-2032) & (US$ Million) Figure 7. Global Haemophilus Influenzae Type B Injection Vaccine Sales (2021-2032) & (K Units) Figure 8. Global Haemophilus Influenzae Type B Injection Vaccine Average Price (US$/Unit) & (2021-2032) Figure 9. Lyophilized Product Image Figure 10. Non-lyophilized Product Image Figure 11. Hospital Product Image Figure 12. Clinic Product Image Figure 13. Global Haemophilus Influenzae Type B Injection Vaccine Revenue Share by Manufacturers in 2025 Figure 14. Global Manufacturers of Haemophilus Influenzae Type B Injection Vaccine, Manufacturing Sites & Headquarters Figure 15. Global Top 5 and 10 Haemophilus Influenzae Type B Injection Vaccine Players Market Share by Revenue in 2025 Figure 16. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Haemophilus Influenzae Type B Injection Vaccine Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 18. Global Haemophilus Influenzae Type B Injection Vaccine Sales by Region in 2025 Figure 19. Global Haemophilus Influenzae Type B Injection Vaccine Revenue by Region in 2025 Figure 20. North America Haemophilus Influenzae Type B Injection Vaccine Market Size by Country in 2025 Figure 21. North America Haemophilus Influenzae Type B Injection Vaccine Sales Market Share by Country (2021-2032) Figure 22. North America Haemophilus Influenzae Type B Injection Vaccine Revenue Market Share by Country (2021-2032) Figure 23. United States Haemophilus Influenzae Type B Injection Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 24. Canada Haemophilus Influenzae Type B Injection Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 25. Europe Haemophilus Influenzae Type B Injection Vaccine Market Size by Country in 2025 Figure 26. Europe Haemophilus Influenzae Type B Injection Vaccine Sales Market Share by Country (2021-2032) Figure 27. Europe Haemophilus Influenzae Type B Injection Vaccine Revenue Market Share by Country (2021-2032) Figure 28. Germany Haemophilus Influenzae Type B Injection Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 29. France Haemophilus Influenzae Type B Injection Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 30. U.K. Haemophilus Influenzae Type B Injection Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. Italy Haemophilus Influenzae Type B Injection Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. Netherlands Haemophilus Influenzae Type B Injection Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. Asia Pacific Haemophilus Influenzae Type B Injection Vaccine Market Size by Country in 2025 Figure 34. Asia Pacific Haemophilus Influenzae Type B Injection Vaccine Sales Market Share by Country (2021-2032) Figure 35. Asia Pacific Haemophilus Influenzae Type B Injection Vaccine Revenue Market Share by Country (2021-2032) Figure 36. China Haemophilus Influenzae Type B Injection Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Japan Haemophilus Influenzae Type B Injection Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. South Korea Haemophilus Influenzae Type B Injection Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. India Haemophilus Influenzae Type B Injection Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Australia Haemophilus Influenzae Type B Injection Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. China Taiwan Haemophilus Influenzae Type B Injection Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. Southeast Asia Haemophilus Influenzae Type B Injection Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 43. Southeast Asia Haemophilus Influenzae Type B Injection Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. South America Haemophilus Influenzae Type B Injection Vaccine Market Size by Country in 2025 Figure 45. South America Haemophilus Influenzae Type B Injection Vaccine Sales Market Share by Country (2021-2032) Figure 46. South America Haemophilus Influenzae Type B Injection Vaccine Revenue Market Share by Country (2021-2032) Figure 47. Mexico Haemophilus Influenzae Type B Injection Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. Brazil Haemophilus Influenzae Type B Injection Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Argentina Haemophilus Influenzae Type B Injection Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Middle East and Africa Haemophilus Influenzae Type B Injection Vaccine Market Size by Country in 2025 Figure 51. Middle East and Africa Haemophilus Influenzae Type B Injection Vaccine Sales Market Share by Country (2021-2032) Figure 52. Middle East and Africa Haemophilus Influenzae Type B Injection Vaccine Revenue Market Share by Country (2021-2032) Figure 53. Turkey Haemophilus Influenzae Type B Injection Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 54. Saudi Arabia Haemophilus Influenzae Type B Injection Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. UAE Haemophilus Influenzae Type B Injection Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Global Haemophilus Influenzae Type B Injection Vaccine Sales Market Share by Type (2021-2032) Figure 57. Global Haemophilus Influenzae Type B Injection Vaccine Revenue Market Share by Type (2021-2032) Figure 58. Global Haemophilus Influenzae Type B Injection Vaccine Price (US$/Unit) by Type (2021-2032) Figure 59. Global Haemophilus Influenzae Type B Injection Vaccine Sales Market Share by Application (2021-2032) Figure 60. Global Haemophilus Influenzae Type B Injection Vaccine Revenue Market Share by Application (2021-2032) Figure 61. Global Haemophilus Influenzae Type B Injection Vaccine Price (US$/Unit) by Application (2021-2032) Figure 62. Haemophilus Influenzae Type B Injection Vaccine Value Chain Figure 63. Haemophilus Influenzae Type B Injection Vaccine Production Mode & Process Figure 64. Direct Comparison with Distribution Share Figure 65. Distributors Profiles Figure 66. Haemophilus Influenzae Type B Injection Vaccine Industry Opportunities and Challenges

Scope & coverage.

Types
  • Lyophilized
  • Non-lyophilized
Applications
  • Hospital
  • Clinic
Companies covered
  • Bharat Biotech
  • Biokangtai
  • Glaxosmithkline
  • Olymvax
  • Sanofi Pasteur
  • Walvax Biotechnology
  • Beijing Minhai Biotechnology Co., Ltd
  • Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd
  • Chengdu Oulin Biotechnology Co., Ltd
  • Chengdu Institute of Biological Products Co., Ltd
  • Lanzhou Institute of Biological Products Co., Ltd
  • Yuxi Watson Biotechnology Co., Ltd

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Haemophilus Influenzae Type B Injection Vaccine Market Size (2021-2032)
  4. 2.2.2 Global Haemophilus Influenzae Type B Injection Vaccine Sales (2021-2032)
  5. 2.2.3 Global Haemophilus Influenzae Type B Injection Vaccine Market Average Price (2021-2032)
  6. 2.3 Haemophilus Influenzae Type B Injection Vaccine by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Lyophilized
  9. 2.3.3 Non-lyophilized
  10. 2.4 Haemophilus Influenzae Type B Injection Vaccine by Application
  11. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  12. 2.4.2 Hospital
  13. 2.4.3 Clinic
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Haemophilus Influenzae Type B Injection Vaccine Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Haemophilus Influenzae Type B Injection Vaccine Sales (K Units) of Manufacturers (2021-2026)
  3. 3.3 Global Haemophilus Influenzae Type B Injection Vaccine Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Haemophilus Influenzae Type B Injection Vaccine Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Haemophilus Influenzae Type B Injection Vaccine Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Haemophilus Influenzae Type B Injection Vaccine, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Haemophilus Influenzae Type B Injection Vaccine, Product Type & Application
  8. 3.8 Global Manufacturers of Haemophilus Influenzae Type B Injection Vaccine, Established Date
  9. 3.9 Global Haemophilus Influenzae Type B Injection Vaccine Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Bharat Biotech
  2. 4.1.1 Bharat Biotech Company Information
  3. 4.1.2 Bharat Biotech Business Overview
  4. 4.1.3 Bharat Biotech Haemophilus Influenzae Type B Injection Vaccine Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Bharat Biotech Haemophilus Influenzae Type B Injection Vaccine Product Portfolio
  6. 4.1.5 Bharat Biotech Recent Developments
  7. 4.2 Biokangtai
  8. 4.2.1 Biokangtai Company Information
  9. 4.2.2 Biokangtai Business Overview
  10. 4.2.3 Biokangtai Haemophilus Influenzae Type B Injection Vaccine Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Biokangtai Haemophilus Influenzae Type B Injection Vaccine Product Portfolio
  12. 4.2.5 Biokangtai Recent Developments
  13. 4.3 Glaxosmithkline
  14. 4.3.1 Glaxosmithkline Company Information
  15. 4.3.2 Glaxosmithkline Business Overview
  16. 4.3.3 Glaxosmithkline Haemophilus Influenzae Type B Injection Vaccine Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Glaxosmithkline Haemophilus Influenzae Type B Injection Vaccine Product Portfolio
  18. 4.3.5 Glaxosmithkline Recent Developments
  19. 4.4 Olymvax
  20. 4.4.1 Olymvax Company Information
  21. 4.4.2 Olymvax Business Overview
  22. 4.4.3 Olymvax Haemophilus Influenzae Type B Injection Vaccine Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Olymvax Haemophilus Influenzae Type B Injection Vaccine Product Portfolio
  24. 4.4.5 Olymvax Recent Developments
  25. 4.5 Sanofi Pasteur
  26. 4.5.1 Sanofi Pasteur Company Information
  27. 4.5.2 Sanofi Pasteur Business Overview
  28. 4.5.3 Sanofi Pasteur Haemophilus Influenzae Type B Injection Vaccine Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Sanofi Pasteur Haemophilus Influenzae Type B Injection Vaccine Product Portfolio
  30. 4.5.5 Sanofi Pasteur Recent Developments
  31. 4.6 Walvax Biotechnology
  32. 4.6.1 Walvax Biotechnology Company Information
  33. 4.6.2 Walvax Biotechnology Business Overview
  34. 4.6.3 Walvax Biotechnology Haemophilus Influenzae Type B Injection Vaccine Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Walvax Biotechnology Haemophilus Influenzae Type B Injection Vaccine Product Portfolio
  36. 4.6.5 Walvax Biotechnology Recent Developments
  37. 4.7 Beijing Minhai Biotechnology Co., Ltd
  38. 4.7.1 Beijing Minhai Biotechnology Co., Ltd Company Information
  39. 4.7.2 Beijing Minhai Biotechnology Co., Ltd Business Overview
  40. 4.7.3 Beijing Minhai Biotechnology Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Beijing Minhai Biotechnology Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Product Portfolio
  42. 4.7.5 Beijing Minhai Biotechnology Co., Ltd Recent Developments
  43. 4.8 Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd
  44. 4.8.1 Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Company Information
  45. 4.8.2 Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Business Overview
  46. 4.8.3 Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Product Portfolio
  48. 4.8.5 Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Recent Developments
  49. 4.9 Chengdu Oulin Biotechnology Co., Ltd
  50. 4.9.1 Chengdu Oulin Biotechnology Co., Ltd Company Information
  51. 4.9.2 Chengdu Oulin Biotechnology Co., Ltd Business Overview
  52. 4.9.3 Chengdu Oulin Biotechnology Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Chengdu Oulin Biotechnology Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Product Portfolio
  54. 4.9.5 Chengdu Oulin Biotechnology Co., Ltd Recent Developments
  55. 4.10 Chengdu Institute of Biological Products Co., Ltd
  56. 4.10.1 Chengdu Institute of Biological Products Co., Ltd Company Information
  57. 4.10.2 Chengdu Institute of Biological Products Co., Ltd Business Overview
  58. 4.10.3 Chengdu Institute of Biological Products Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Chengdu Institute of Biological Products Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Product Portfolio
  60. 4.10.5 Chengdu Institute of Biological Products Co., Ltd Recent Developments
  61. 4.11 Lanzhou Institute of Biological Products Co., Ltd
  62. 4.11.1 Lanzhou Institute of Biological Products Co., Ltd Company Information
  63. 4.11.2 Lanzhou Institute of Biological Products Co., Ltd Business Overview
  64. 4.11.3 Lanzhou Institute of Biological Products Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Lanzhou Institute of Biological Products Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Product Portfolio
  66. 4.11.5 Lanzhou Institute of Biological Products Co., Ltd Recent Developments
  67. 4.12 Yuxi Watson Biotechnology Co., Ltd
  68. 4.12.1 Yuxi Watson Biotechnology Co., Ltd Company Information
  69. 4.12.2 Yuxi Watson Biotechnology Co., Ltd Business Overview
  70. 4.12.3 Yuxi Watson Biotechnology Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Yuxi Watson Biotechnology Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Product Portfolio
  72. 4.12.5 Yuxi Watson Biotechnology Co., Ltd Recent Developments
5 Global Haemophilus Influenzae Type B Injection Vaccine Market Scenario by Region
  1. 5.1 Global Haemophilus Influenzae Type B Injection Vaccine Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Haemophilus Influenzae Type B Injection Vaccine Sales by Region: 2021-2032
  3. 5.2.1 Global Haemophilus Influenzae Type B Injection Vaccine Sales by Region: 2021-2026
  4. 5.2.2 Global Haemophilus Influenzae Type B Injection Vaccine Sales by Region: 2027-2032
  5. 5.3 Global Haemophilus Influenzae Type B Injection Vaccine Revenue by Region: 2021-2032
  6. 5.3.1 Global Haemophilus Influenzae Type B Injection Vaccine Revenue by Region: 2021-2026
  7. 5.3.2 Global Haemophilus Influenzae Type B Injection Vaccine Revenue by Region: 2027-2032
  8. 5.4 North America Haemophilus Influenzae Type B Injection Vaccine Market Facts & Figures by Country
  9. 5.4.1 North America Haemophilus Influenzae Type B Injection Vaccine Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Haemophilus Influenzae Type B Injection Vaccine Sales by Country (2021-2032)
  11. 5.4.3 North America Haemophilus Influenzae Type B Injection Vaccine Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.5 Europe Haemophilus Influenzae Type B Injection Vaccine Market Facts & Figures by Country
  15. 5.5.1 Europe Haemophilus Influenzae Type B Injection Vaccine Market Size by Country: 2021 VS 2025 VS 2032
  16. 5.5.2 Europe Haemophilus Influenzae Type B Injection Vaccine Sales by Country (2021-2032)
  17. 5.5.3 Europe Haemophilus Influenzae Type B Injection Vaccine Revenue by Country (2021-2032)
  18. 5.5.4 Germany
  19. 5.5.5 France
  20. 5.5.6 U.K.
  21. 5.5.7 Italy
  22. 5.5.8 Netherlands
  23. 5.6 Asia Pacific Haemophilus Influenzae Type B Injection Vaccine Market Facts & Figures by Country
  24. 5.6.1 Asia Pacific Haemophilus Influenzae Type B Injection Vaccine Market Size by Country: 2021 VS 2025 VS 2032
  25. 5.6.2 Asia Pacific Haemophilus Influenzae Type B Injection Vaccine Sales by Country (2021-2032)
  26. 5.6.3 Asia Pacific Haemophilus Influenzae Type B Injection Vaccine Revenue by Country (2021-2032)
  27. 5.6.4 China
  28. 5.6.5 Japan
  29. 5.6.6 South Korea
  30. 5.6.7 India
  31. 5.6.8 Australia
  32. 5.6.9 China Taiwan
  33. 5.6.10 Southeast Asia
  34. 5.7 South America Haemophilus Influenzae Type B Injection Vaccine Market Facts & Figures by Country
  35. 5.7.1 South America Haemophilus Influenzae Type B Injection Vaccine Market Size by Country: 2021 VS 2025 VS 2032
  36. 5.7.2 South America Haemophilus Influenzae Type B Injection Vaccine Sales by Country (2021-2032)
  37. 5.7.3 South America Haemophilus Influenzae Type B Injection Vaccine Revenue by Country (2021-2032)
  38. 5.7.4 Mexico
  39. 5.7.5 Brazil
  40. 5.7.6 Argentina
  41. 5.8 Middle East and Africa Haemophilus Influenzae Type B Injection Vaccine Market Facts & Figures by Country
  42. 5.8.1 Middle East and Africa Haemophilus Influenzae Type B Injection Vaccine Market Size by Country: 2021 VS 2025 VS 2032
  43. 5.8.2 Middle East and Africa Haemophilus Influenzae Type B Injection Vaccine Sales by Country (2021-2032)
  44. 5.8.3 Middle East and Africa Haemophilus Influenzae Type B Injection Vaccine Revenue by Country (2021-2032)
  45. 5.8.4 Turkey
  46. 5.8.5 Saudi Arabia
  47. 5.8.6 UAE
6 Segment by Type
  1. 6.1 Global Haemophilus Influenzae Type B Injection Vaccine Sales by Type (2021-2032)
  2. 6.1.1 Global Haemophilus Influenzae Type B Injection Vaccine Sales by Type (2021-2032) & (K Units)
  3. 6.1.2 Global Haemophilus Influenzae Type B Injection Vaccine Sales Market Share by Type (2021-2032)
  4. 6.2 Global Haemophilus Influenzae Type B Injection Vaccine Revenue by Type (2021-2032)
  5. 6.2.1 Global Haemophilus Influenzae Type B Injection Vaccine Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Haemophilus Influenzae Type B Injection Vaccine Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Haemophilus Influenzae Type B Injection Vaccine Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Haemophilus Influenzae Type B Injection Vaccine Sales by Application (2021-2032)
  2. 7.1.1 Global Haemophilus Influenzae Type B Injection Vaccine Sales by Application (2021-2032) & (K Units)
  3. 7.1.2 Global Haemophilus Influenzae Type B Injection Vaccine Sales Market Share by Application (2021-2032)
  4. 7.2 Global Haemophilus Influenzae Type B Injection Vaccine Revenue by Application (2021-2032)
  5. 7.2.1 Global Haemophilus Influenzae Type B Injection Vaccine Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Haemophilus Influenzae Type B Injection Vaccine Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Haemophilus Influenzae Type B Injection Vaccine Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Haemophilus Influenzae Type B Injection Vaccine Value Chain Analysis
  2. 8.1.1 Haemophilus Influenzae Type B Injection Vaccine Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Haemophilus Influenzae Type B Injection Vaccine Production Mode & Process
  5. 8.2 Haemophilus Influenzae Type B Injection Vaccine Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Haemophilus Influenzae Type B Injection Vaccine Distributors
  8. 8.2.3 Haemophilus Influenzae Type B Injection Vaccine Customers
9 Global Haemophilus Influenzae Type B Injection Vaccine Analyzing Market Dynamics
  1. 9.1 Haemophilus Influenzae Type B Injection Vaccine Industry Trends
  2. 9.2 Haemophilus Influenzae Type B Injection Vaccine Industry Drivers
  3. 9.3 Haemophilus Influenzae Type B Injection Vaccine Industry Opportunities and Challenges
  4. 9.4 Haemophilus Influenzae Type B Injection Vaccine Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst